← Back to patent-cliff list
CAS 603-35-0
triphenylphosphanePhosphorustriphenyl
Codes: LACO-030, Voclosporin-011
Application context (from source-drug indications)
Tonic-clonic seizureLacosamideEpilepsyLacosamidePartial-onset seizureLacosamideSeizureLacosamide狼疮肾炎VoclosporinKidney transplant rejectionVoclosporinCOVID-19VoclosporinSystemic lupus erythematosusVoclosporin局灶性节段性肾小球硬化症VoclosporinDry eye syndromeVoclosporin
Source drugs (routes using this intermediate)
| Drug | Tier | Expiry |
|---|---|---|
| Lacosamide | Tier B — Position early | 2028 |
| Voclosporin | Tier C — Watch / trade | - |
Position in synthesis routes (up/downstream chain)
Ordered by route registration; left → right is the synthesis direction. The highlighted node is the current CAS; others link to their own profiles.
phenylmethanamine→N-acetyl-O-methyl-D-serine→methyl D-serinate→diethoxytriphenyl-l5-phosphane→ethyl (R)-aziridine-2-carboxylate→methyl (R)-aziridine-2-carboxylate→ethyl (R)-1-acetylaziridine-2-carboxylate→methyl (R)-1-acetylaziridine-2-carboxylate→ethyl N-acetyl-O-methyl-D-serinate→methyl N-acetyl-O-methyl-D-serinate→4-(4,6-dimethoxy-1,3,5-triazin-2-yl)-4-methylmorpholin-4-ium chloride→triphenylphosphane→sodium ethanolate
Phosphorustriphenyl→(1R,2R,4E)-1-[(2S,5S,11S,14S,17S,20S,23R,26S,29S,32S)-5-Ethyl-1,7,10,16,20,23,25,28,31-nonamethyl-11,17,26,29-tetrakis(2-methylpropyl)-3,6,9,12,15,18,21,24,27,30,33-undecaoxo-14,32-di(propan-2-yl)-1,4,7,10,13,16,19,22,25,28,31-undecaazacyclotritriacontan-2-yl]-2-methylhex-4-en-1-ylacetate→(1R,2R,4E)-6-bromo-1-[(2S,5S,11S,14S,17S,20S,23R,26S,29S,32S)-5-ethyl-1,7,10,16,20,23,25,28,31-nonamethyl-11,17,26,29-tetrakis(2-methylpropyl)-3,6,9,12,15,18,21,24,27,30,33-undecaoxo-14,32-bis(propan-2-yl)-1,4,7,10,13,16,19,22,25,28,31-undecaazacyclotritriacontan-2-yl]-2-methylhex-4-en-1-ylacetate→[(2E,5R,6R)-6-(acetyloxy)-6-[(2S,5S,11S,14S,17S,20S,23R,26S,29S,32S)-5-ethyl-1,7,10,16,20,23,25,28,31-nonamethyl-11,17,26,29-tetrakis(2-methylpropyl)-3,6,9,12,15,18,21,24,27,30,33-undecaoxo-14,32-bis(propan-2-yl)-1,4,7,10,13,16,19,22,25,28,31-undecaazacyclotritriacontan-2-yl]-5-methylhex-2-en-1-yl]triphenylphosphoniumbromide
Intermediates available on this site
No listed intermediates for this target yet — send an RFQ directly and it will enter our matching pool.
This is a CAS-level registry record: registrations across routes are merged. Supplier offers and buyer demands will be matched on this CAS as the primary key.